-
EP1720531
European procedure
Extract from the Register of European Patents
EP About this file: EP1720531
| EP1720531 - NEW COMPOSITIONS CONTAINING QUINOLINE COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.02.2012 Database last updated on 01.04.2026 | Most recent event Tooltip | 17.02.2012 | No opposition filed within time limit | published on 21.03.2012 [2012/12] | Applicant(s) | For all designated states Active Biotech AB Box 724 220 07 Lund / SE | [2006/46] | Inventor(s) | 01 /
JANSSON, Karl Spannm lsvägen 11 S-240 10 Dalby / SE | 02 /
FRISTEDT, Tomas Byalagsgatan 54 S-256 56 Helsingborg / SE | 03 /
WÄNNMAN, Hans Apelvägen 40 S-262 65 Ängelholm / SE | 04 /
BJÖRK, Anders Svalvägen 9 S-237 36 Bjärred / SE | [2006/46] | Representative(s) | Allee, Harriet Eva Charlotta, et al BRANN AB P.O. Box 12246 102 26 Stockholm / SE | [N/P] |
| Former [2006/46] | Allee, Harriet Eva Charlotta, et al Dr Ludwig Brann Patentbyra AB, Box 17192 104 62 Stockholm / SE | Application number, filing date | 05707942.8 | 04.02.2005 | [2006/46] | WO2005EP50485 | Priority number, date | SE20040000235 | 06.02.2004 Original published format: SE 0400235 | [2006/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005074899 | Date: | 18.08.2005 | Language: | EN | [2005/33] | Type: | A2 Application without search report | No.: | EP1720531 | Date: | 15.11.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.08.2005 takes the place of the publication of the European patent application. | [2006/46] | Type: | B1 Patent specification | No.: | EP1720531 | Date: | 13.04.2011 | Language: | EN | [2011/15] | Search report(s) | International search report - published on: | EP | 19.04.2007 | Classification | IPC: | A61K31/00 | [2006/46] | CPC: |
A61K31/47 (EP,US);
A61K31/4704 (NO);
A61K31/4709 (KR);
A61K31/4706 (EP,US);
A61P29/00 (EP);
A61P37/00 (EP);
A61P43/00 (EP);
C07D215/22 (NO);
A61K9/1617 (EP,US);
A61K9/2009 (EP,US);
A61K9/2013 (EP,US);
A61K9/2054 (EP,US);
A61K9/2059 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/46] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | LV | 30.08.2006 | MK | Not yet paid | YU | Not yet paid | Title | German: | NEUE ZUSAMMENSETZUNGEN MIT CHINOLIN-VERBINDUNGEN | [2006/46] | English: | NEW COMPOSITIONS CONTAINING QUINOLINE COMPOUNDS | [2006/46] | French: | NOUVELLES COMPOSITIONS CONTENANT DES COMPOSES DE QUINOLINE | [2006/46] | Entry into regional phase | 30.08.2006 | National basic fee paid | 30.08.2006 | Designation fee(s) paid | 30.08.2006 | Examination fee paid | Examination procedure | 30.08.2006 | Examination requested [2006/46] | 27.09.2007 | Despatch of a communication from the examining division (Time limit: M04) | 07.12.2007 | Reply to a communication from the examining division | 09.03.2009 | Despatch of a communication from the examining division (Time limit: M04) | 11.06.2009 | Reply to a communication from the examining division | 30.04.2010 | Despatch of a communication from the examining division (Time limit: M02) | 12.05.2010 | Reply to a communication from the examining division | 21.09.2010 | Communication of intention to grant the patent | 28.12.2010 | Fee for grant paid | 28.12.2010 | Fee for publishing/printing paid | Opposition(s) | 16.01.2012 | No opposition filed within time limit [2012/12] | Fees paid | Renewal fee | 23.02.2007 | Renewal fee patent year 03 | 20.02.2008 | Renewal fee patent year 04 | 20.02.2009 | Renewal fee patent year 05 | 23.02.2010 | Renewal fee patent year 06 | 24.02.2011 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||